Top Markets
Coin of the day
Mabion S.A. Mabion S.A.

Mabion S.A.

MAB
Rang in Aktien #27026
Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the... Mabion S.A. is a Polish biopharmaceutical firm dedicated to pioneering the development of biological drugs, primarily leveraging monoclonal antibody technology. The company oversees the full spectrum from research and development to the manufacturing and commercialization of therapies designed to combat a wide range of diseases, including neoplastic (cancer), autoimmune, metabolic, and neurological disorders. Key products in its portfolio include MabionCD20 and MabionHER2. Established in 2007, Mabion S.A. maintains its headquarters in Konstantynów Lódzki, Poland.
Aktienkurs
$2.20
Marktkapitalisierung
$35.63M
Veränderung (1 Tag)
2.49%
Veränderung (1 Jahr)
-15.59%
Land
PL
Handel Mabion S.A. (MAB)

Kategorie

Kursverlauf für Mabion S.A. (MAB)
Höchster Schlusskurs: $2.13 am 2026-08-01

Niedrigster Schlusskurs: $4.20 am 2010-08-01
Kursverlauf der Aktie von Mabion S.A. von 2010 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 12.10%
2025 -19.31%
2024 -48.95%
2023 -2.07%
2022 -70.98%
2021 195.71%
2020 -72.42%
2019 -11.04%
2018 -20.35%
2017 62.87%
2016 57.30%
2015 6.33%
2014 -9.21%
2013 146.12%
2012 58.68%
2011 -42.39%
2010 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$756.93 6.35%
CH